A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Items 301–400 of 1,000
Kanoe, H., Nakayama, T., Hosaka, T., Murakami, H., Yamamoto, H., Nakashima, Y., Tsuboyama, T., Nakamura, T., Ron, D., Sasaki, M. S., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202364 · Cited by 68
“The fusion of the BCR and c-ABL genes on the Philadelphia chromosome in chronic myelogenous leukemia typi®es this class of rearrangement (De Klein et al., 1982).”
BackgroundClonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice
Voncken, J., Morris, C. M., Pattengale, P. K., Dennert, G., Kikly, C., Groffen, J., & Heisterkamp, N. (1992) · Blood · doi:10.1182/blood.v79.4.1029.1029 · Cited by 68
Self-citationBhatia, R., & Verfaillie, C. M. (1998) · Blood · doi:10.1182/blood.v91.9.3414 · Cited by 68
Pouwer, M. G., Pieterman, E. J., Verschuren, L., Caspers, M. P. M., Kluft, C., Garcia, R. A., Aman, J., Jukema, J. W., & Princen, H. M. G. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00055 · Cited by 68
Origins of Mammalian Hematopoiesis: In Vivo Paradigms and In Vitro Models
Lensch, M. W., & Daley, G. Q. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)60005-6 · Cited by 79
Brunner, A. M., Campigotto, F., Sadrzadeh, H., Drapkin, B. J., Chen, Y., Neuberg, D. S., & Fathi, A. T. (2013) · Cancer · doi:10.1002/cncr.28106 · Cited by 75
Expression of p210 and p190 BCL-ABL due to alternative splicing in chronic myelogenous leukaemia
Lichty, B. D., Keating, A., Callum, J., Yee, K. W. L., Croxford, R., Corpus, G., Nwachukwu, B., Kim, P., Guo, J., & Kamel‐Reid, S. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01033.x · Cited by 67
“…Philadelphia chromosome (Ph); the result of a t(9;22) (q34;q11) reciprocal translocation and subsequent fusion of the c-ABL proto-oncogene on chromosome 9 with the BCR gene on chromosome 22 (Nowell & Hungerford, 1960; Rowley, 1973; de Klein et al, 1982; Groffen et al, 1984; Ben-Nariah et al, 1986).”
BackgroundDillmann, F., Veldwijk, M. R., Laufs, S., Sperandio, M., Calandra, G., Wenz, F. K., Zeller, W. J., & Früehauf, S. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190903150847 · Cited by 67
“The pathogenetic hallmark and a prerequisite for CML is the ‘Philadelphia chromosome’ [1], a t(9;22)(q34;q11) translocation, that generates the BCR-ABL fusion gene [2].”
BackgroundType II Transmembrane Serine Protease (TTSP) deregulation in cancer
Siobhan, L. W. (2010) · Frontiers in bioscience · doi:10.2741/3704 · Cited by 70
“In the second, the rearrangement fuses two genes, resulting in the production of a fusion protein that may have a new or altered activity (88, 89).”
BackgroundCLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY
Kantarjian, H. M., Giles, F. J., O'Brien, S. M., & Talpaz, M. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70496-2 · Cited by 67
Huhn, R. D., Posner, M. R., Rayter, S., Foulkes, J. G., & Frackelton, A. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4408 · Cited by 67
Constitutional translocation t(3;6)(p14;p11) in a family with hematologic malignancies
Markkanen, A., Ruutu, T., Rasi, V., Franssila, K., Knuutila, S., & de la Chapelle, A. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90163-4 · Cited by 67
Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine
Dupain, C., Harttrampf, A. C., Urbinati, G., Geoerger, B., & Massaad-Massade, L. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.01.005 · Cited by 73
“MLL4-GPS2 t(17;19) spindle cell sarcoma 161 poor”
BackgroundInfluentialMolecular Basis of Mature T-Cell Leukemia
Pekarsky, Y. (2001) · JAMA · doi:10.1001/jama.286.18.2308 · Cited by 66
Tommerup, N., Nielsen, F., & Opitz, J. M. (1983) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320160304 · Cited by 66
Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia
Roskoski, R. J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106156 · Cited by 70
Hawn, T. R., Shah, J. A., & Kalman, D. (2015) · Immunological Reviews · doi:10.1111/imr.12255 · Cited by 71
Activation of the abl oncogene in murine and human leukemias
Konopka, J. B., & Witte, O. N. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(85)90012-5 · Cited by 75
Epstein–Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue
Bornkamm, G. W. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.07.002 · Cited by 76
TATA box polymorphisms in human gene promoters and associated hereditary pathologies
Savinkova, L. K., Ponomarenko, M. P., Пономаренко, П. М., Drachkova, I. A., Lysova, M. V., Arshinova, T., & Kolchanov, N. A. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909020011 · Cited by 79
Inokuchi, K., Inoue, T. K., Tojo, A., Futaki, M., Miyake, K., Yamada, T., Tanabe, Y., Ohki, I., Dan, K., & OZAWA, K. (1991) · Blood · doi:10.1182/blood.v78.12.3125.3125 · Cited by 64
Humanbcr-abl gene has a lethal effect on embryogenesis
Heisterkamp, N., Jenster, G. W., Kioussis, D., Pattengale, P. K., & Groffen, J. (1991) · Transgenic Research · doi:10.1007/bf02512996 · Cited by 64
Self-citationImproving outcomes for high‐risk ALL: Translating new discoveries into clinical care
Hunger, S. P., Raetz, E. A., Loh, M. L., & Mullighan, C. G. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22996 · Cited by 71
“gene to ABL1 (the human homologue of the Abelson murine leukemia virus) on chromosome 9 and produced chimeric BCRABL1 transcripts and a BCR-ABL1 fusion protein of 210 kDa (almost all CML cases) or 190 kDa (most Phþ ALL cases) [47,48].”
BackgroundThe Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells
Rushworth, S. A., & MacEwan, D. J. (2011) · Cancers · doi:10.3390/cancers3021605 · Cited by 69
“The resulting fusion of the c-Abl- and BCR genes generates the BCR/Abl oncogene, which encodes a 210 kDa oncoprotein, BCR/Abl, exhibiting constitutive Abelson tyrosine kinase (TK) activity [64].”
BackgroundTefferi, A., Dewald, G. W., Litzow, M. L., Cortes, J. E., Mauro, M. J., Talpaz, M., & Kantarjian, H. M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.3.390 · Cited by 78
Kurzrock, R., Ku, S., & Talpaz, M. (1995) · Cancer · doi:10.1002/1097-0142(19950115)75:2<584::aid-cncr2820750223>3.0.co;2-p · Cited by 58
Linkage of the tuberous sclerosis locus to a DNA polymorphism detected by v-abl.
Connor, J. M., Pirrit, L. A., Yates, J. R. W., Fryer, A. E., & Ferguson-Smith, M. A. (1987) · Journal of Medical Genetics · doi:10.1136/jmg.24.9.544 · Cited by 63
Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia.
Denderen, J. V., Hermans, A., Boer, T. M.-D., Troelstra, C., Zegers, N. D., Boersma, W. J. A., Grosveld, G. C., & van Ewijk, W. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.87 · Cited by 63
Self-citationBeider, K., Darash‐Yahana, M., Blaier, O., Koren‐Michowitz, M., Abraham, M., Wald, H., Wald, O., Galun, E., Eizenberg, O., Peled, A., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0410 · Cited by 66
“Inhibition of BCR-ABL activity by tyrosine kinase inhibitors (TKI), such as imatinib mesylate, revolutionized the treatment of CML and remains a major therapeutic strategy for patients with CML (3).”
BackgroundInfluentialGenomic rearrangements induced by unscheduled DNA double strand breaks in somatic mammalian cells
So, A., Guen, T. L., López, B. S., & Guirouilh‐Barbat, J. (2017) · FEBS Journal · doi:10.1111/febs.14053 · Cited by 82
Goate, A., Cooper, D. N., Hall, C., LEUNG, T. K. C., Solomon, E., & Lim, L. (1987) · Human Genetics · doi:10.1007/bf00591072 · Cited by 62
“C121E (Croce and Koprowski 1974); MCP6, G3.32.2 (Goodfellow et al. 1982b); DUR4R3 (Solomon et al. 1976); HORP 9.5, HorlI, Horl 9D2R1 (Goodfellow et al. 1982a); DT1.2.4 (Swallow et al. 1977); C4a (hamster-human hybrid) (Carritt 1980); PgMe25 ( de Klein et al. 1982 ); LSR34-S49, LSR34 ÷ $49 (Spurr et al. 1986); A9 (Tan…”
InfluentialMorris, C. M., Heisterkamp, N., Kennedy, M. A., Fitzgerald, P. H., & Groffen, J. (1990) · Blood · doi:10.1182/blood.v76.9.1812.1812 · Cited by 62
Self-citationCytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
Hoermann, G., Greiner, G., & Valent, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/869242 · Cited by 61
Cancer Cytogenetics: Methodology Revisited
Wan, T. S. K. (2014) · Annals of Laboratory Medicine · doi:10.3343/alm.2014.34.6.413 · Cited by 61
The interferon-alpha revival in CML
Talpaz, M., Mercer, J., & Hehlmann, R. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2326-y · Cited by 69
Valent, P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07197.x · Cited by 66
“Chronic myeloid leukaemia (CML) is a haematopoietic stem cell neoplasm defined by the t(9;22) and the related oncogene, BCR/ABL1-p210 (previously termed BCR/ABL-p210) (Nowell & Hungerford, 1960; Rowley, 1973; de Klein et al, 1982).”
BackgroundCD44-SLC1A2 Gene Fusions in Gastric Cancer
Tao, J., Deng, N., Ramnarayanan, K., Huang, B., Oh, H. K., Leong, S. H., Lim, S. S., Tan, I. B., Ooi, C.-H., Wu, J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001423 · Cited by 65
Carrera, C. J., Eddy, R. L., Shows, T. B., & Carson, D. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2665 · Cited by 61
Targeted therapies for the treatment of cancer
Kim, J. A. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00212-5 · Cited by 61
Swolin, B., Weinfeld, A., Westin, J., Waldenström, J., & Magnusson, B. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90041-x · Cited by 61
Drabkin, H. A., Diaz, M., Bradley, C. M., Le Beau, M. M., Rowley, J. D., & Patterson, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.464 · Cited by 61
Acute leukemias?prognostic factors and treatment strategies
B�chner, T. (1989) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00400972 · Cited by 61
The legacy of the Philadelphia chromosome
Koretzky, G. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33032 · Cited by 66
Chronic Myeloid Leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 Activity
Engler, J. R., Frede, A., Saunders, V. A., Zannettino, A. C. W., Hughes, T. P., & White, D. L. (2010) · Leukemia · doi:10.1038/leu.2010.16 · Cited by 64
Gibson, T. J., Dinkel, H., Van Roey, K., & Diella, F. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0121-y · Cited by 62
Modi, H., McDonald, T., Chu, S., Yee, J., Forman, S. J., & Bhatia, R. (2007) · Blood · doi:10.1182/blood-2006-06-032490 · Cited by 69
Mayerhofer, M., Aichberger, K. J., Florian, S., Krauth, M., Hauswirth, A. W., Derdak, S. V., Sperr, W. R., Esterbauer, H., Wagner, O. F., Marosi, C., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-1973fje · Cited by 65
Naldini, L., Stacchini, A., Cirillo, D. M., Aglietta, M., Gavosto, F., & Comoglio, P. M. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1803 · Cited by 60
Chronic myeloid leukemia from basics to bedside
Thijsen, S. F. T., Schuurhuis, G. J., Oostveen, J. W. V., & Ossenkoppele, G. J. (1999) · Leukemia · doi:10.1038/sj.leu.2401565 · Cited by 68
THE MOLECULAR BIOLOGY OF CHRONIC MYELOGENOUS LEUKAEMIA
Gale, R. P., & Cannani, E. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07436.x · Cited by 60
Variant Ph translocations in chronic myeloid leukemia
Heim, S., Billström, R., Kristoffersson, U., Mandahl, N., Strömbeck, B., & Mitelman, F. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90086-x · Cited by 59
Siracusa, L. D., Abbott, C. M., Morgan, J. L., Zuberi, A. R., Pomp, D., & Peters, J. (1997) · Mammalian Genome · doi:10.1007/s003359900314 · Cited by 59
BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia
Xu, C., Fu, H., Gao, L., Wang, L., Wang, W., Li, J., Li, Y., Dou, L., Gao, X., Luo, X., et al. (2014) · Oncogene · doi:10.1038/onc.2012.557 · Cited by 58
Science and Technology for Disease Control: Past, Present, and Future
Weatherall, D. J., Greenwood, B. M., Chee, H. L., & Wasi, P. (2006) · Europe PMC (PubMed Central) · Cited by 58
Aneuploidy in pluripotent stem cells and implications for cancerous transformation
Na, J., Baker, D., Zhang, J., Andrews, P. W., & Barbaric, I. (2014) · Protein & Cell · doi:10.1007/s13238-014-0073-9 · Cited by 63
“…chromosomes 9 and 22 (Philadelphia chromosome) (Nowell and Hungerford, 1960; Rowley, 1973) led to identification of the BCR/ABL1 gene fusion (de Klein et al., 1982), which is created at the join between the two chromosomes and is now used for highly successfully targeted therapy in chronic…”
BackgroundThe molecular genetics of the multiple endocrine neoplasia syndromes
Thakker, R. V. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00964.x · Cited by 59
Proto-Oncogenes and Tumor Suppressor Genes in Human Urological Malignancies
Strohmeyer, T. G., & Slamon, D. J. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)35284-9 · Cited by 58
STI571 as a Targeted Therapy for CML
O'Dwyer, M. E., Mauro, M. J., & Druker, B. J. (2003) · Cancer Investigation · doi:10.1081/cnv-120018235 · Cited by 63
CONSEQUENCES OF CHROMOSOMAL ABNORMALITIES IN TUMOR DEVELOPMENT
Sánchez-García, I. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.429 · Cited by 63
Chromosomal Abnormalities in Leukemia and Lymphoma: Clinical and Biological Significance
Beau, M. M. L., & Rowley, J. D. (1986) · Springer eBooks · doi:10.1007/978-1-4615-8356-1_1 · Cited by 58
Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Strife, A., Lambek, C. L., Wisniewski, D. J., Wachter, M., Gulati, S. C., & Clarkson, B. D. (1988) · PubMed · Cited by 58
Azim, H., Gentilini, O., Locatelli, M., Ciriello, E., Scarfone, G., & Peccatori, F. A. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2011.204 · Cited by 58
Aloisi, A., Gregorio, S. D., Stagno, F., Guglielmo, P., Mannino, F., Sormani, M. P., Bruzzi, P., Gambacorti-Passerini, C. B., Saglio, G. N., Venuta, S., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2123 · Cited by 57
Detection of minimal residual disease
Dölken, G. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)82005-4 · Cited by 62
Elefanty, A. G., & Cory, S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1755 · Cited by 57
Significance of chromosome change to hematopoietic neoplasms
CHAGANTI, R. S. K. (1983) · Blood · doi:10.1182/blood.v62.3.515.515 · Cited by 57
Chromosomal assignment of a family of human oncogenes.
Ryan, J., Barker, P. E., Shimizu, K., Wigler, M. H., & Ruddle, F. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4460 · Cited by 57
Current approach to the treatment of chronic myeloid leukaemia
Pašić, I., & Lipton, J. H. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.01.005 · Cited by 60
Chromosome assignments of four mouse cellular homologs of sarcoma and leukemia virus oncogenes.
Sakaguchi, A. Y., Lalley, P. A., Zabel, B., Ellis, R. W., Scolnick, E. M., & Naylor, S. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.2.525 · Cited by 56
Liang, X., Wisniewski, D. J., Strife, A., Shivakrupa, Clarkson, B. D., & Resh, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200277200 · Cited by 65
Genetic analysis of the 15;17 chromosome translocation associated with acute promyelocytic leukemia.
Sheer, D., Hiorns, L. R., Stanley, K., Goodfellow, P. N., Swallow, D. M., Povey, S., Heisterkamp, N., Groffen, J., Stephenson, J. R., & Solomon, E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.16.5007 · Cited by 55
Self-citationTachibana, N., Raimondi, S. C., Lauer, S. J., Sartain, P., & Dow, L. W. (1987) · Blood · doi:10.1182/blood.v70.5.1458.1458 · Cited by 55
ASXL1/2 mutations and myeloid malignancies
Medina, E. A., Delma, C. R., & Yang, F. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01336-x · Cited by 63
Tefferi, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00559.x · Cited by 58
“In 1982, the human homologue (ABL1; 225 kb total gene size) of v-abl was mapped to chromosome 9 [26] and shown to be involved in the Ph translocation [27].”
BackgroundJain, N., Reuben, J. M., Kantarjian, H. M., Li, C., Gao, H., Lee, B.-N., Cohen, E. N., Ebarb, T., Scheinberg, D. A., & Cortes, J. E. (2009) · Cancer · doi:10.1002/cncr.24468 · Cited by 54
Cheng, Y., Idrees, K., Shattock, R., Khan, S. A., Zeng, Z., Brennan, C., Paty, P. B., & Barany, F. (2009) · International Journal of Cancer · doi:10.1002/ijc.25086 · Cited by 60
“A well-known example is the BCR-ABL fusion protein in chronic myelogenous leukemia where the ABL proto-oncogene was activated by the 50 activation region of BCR.(30,31) Recently, gene fusion has also been identified in epithelial tumors.”
BackgroundZhao, L., Li, Y., Song, X., Zhou, H., Li, N., Miao, Y., & Li, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11054 · Cited by 54
“Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by BCRABL fusion gene [1].”
Jc, K., Aurias, A., Julier, C., Prieur, M., & Szajnert, M. (1987) · Journal of Medical Genetics · doi:10.1136/jmg.24.2.65 · Cited by 54
Restricted oncogenicity of BCR/ABL p190 in transgenic mice.
Voncken, J. W., Griffiths, S., Greaves, M. F., Pattengale, P. K., Heisterkamp, N., & Groffen, J. (1992) · PubMed · Cited by 54
Self-citationMaxwell, S. A., Kurzrock, R., Parsons, S. J., Talpaz, M., Gallick, G. E., Kloetzer, W. S., Arlinghaus, R. B., KOUTTAB, N. M., Keating, M. J., & Gutterman, J. U. (1987) · PubMed · Cited by 54
Vaerman, J., Lammineur, C., Moureau, P., Lewalle, P., Deldime, F., BLUMENFELD, M. L., & Martiat, P. (1995) · Blood · doi:10.1182/blood.v86.10.3891.bloodjournal86103891 · Cited by 54
The BCL-2 protein family: from discovery to drug development
Croce, C. M., Vaux, D. L., Strasser, A., Opferman, J. T., Czabotar, P. E., & Fesik, S. W. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01481-z · Cited by 71
Cerny‐Reiterer, S., Ghanim, V., Hoermann, G., Aichberger, K. J., Herrmann, H., Müllauer, L., Repa, A., Sillaber, C., Walls, A. F., Mayerhofer, M., et al. (2012) · Neoplasia · doi:10.1593/neo.12724 · Cited by 56
“This cytogenetic defect creates the BCR-ABL1 fusion gene [2,3].”
BackgroundMolecular biology of chronic myeloid leukemia
Maru, Y. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02346.x · Cited by 60
MacConaill, L. E., Van Hummelen, P., Meyerson, M., & Hahn, W. C. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0110 · Cited by 54
In vivo chromosomal instability in ataxia-telangiectasia homozygotes and heterozygotes
Rosin, M. P., & Ochs, H. D. (1986) · Human Genetics · doi:10.1007/bf00280482 · Cited by 53
Morel, F., Herry, A., Bris, M. ‐. L., Morice, P., Bouquard, P., Abgrall, J. F., Berthou, C., & Braekeleer, M. D. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00204-8 · Cited by 53
The Biology of Normal and Neoplastic Stem Cells in CML
Eaves, C. J., Udomsakdi, C., Cashman, J., Barnett, M. I., & Eaves, A. C. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309047894 · Cited by 53
Ishihara, T., & Minamihisamatsu, M. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90314-7 · Cited by 53
10 Multiple endocrine neoplasia
Thakker, R. V., & Ponder, B. A. J. (1988) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(88)80029-6 · Cited by 56
Martiat, P., Lewalle, P., Taj, A. S., Philippe, M., Larondelle, Y., Vaerman, J., Wildmann, C., Goldman, J. M., & Michaux, J. (1993) · Blood · doi:10.1182/blood.v81.2.502.502 · Cited by 53
Histological and cytogenetic findings in a malignant tumor of the chest wall and lung (Askin tumor)
Seemayer, T. A., Vekemans, M. J. J., & Chadar�vian, J.-P. (1985) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00707991 · Cited by 53
Isolation of v-fms and its human cellular homolog
Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1983) · Virology · doi:10.1016/0042-6822(83)90476-2 · Cited by 53
Self-citationCloning of Breakpoints of a Chromosome Translocation Identifies the AN2 Locus
Gessler, M., Simola, K. O. J., & Bruns, G. A. P. (1989) · Science · doi:10.1126/science.2544995 · Cited by 53
The first BCR gene intron contains breakpoints in Philadelphla chromosome positive leukemia
Heisterkamp, N., Knoppel, E., & Groffen, J. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.21.10069 · Cited by 53
Self-citationThe Emerging Genetics of Human Cancer
Epstein, F. H., & Krontiris, T. G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090704 · Cited by 53
Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.
Jena, N., Deng, M., Sicinska, E., Siciński, P., & Daley, G. Q. (2002) · PubMed · Cited by 58
Chopra, R., Pu, Q. Q., & Elefanty, A. G. (1999) · Blood Reviews · doi:10.1054/blre.1999.0119 · Cited by 53
Verfaillie, C. M., Kay, N. E., Miller, W., & McGlave, P. B. (1990) · Blood · doi:10.1182/blood.v76.2.401.401 · Cited by 52
Non‐random chromosomal aberrations associated with multiple myeloma
Lewis, J. P., & MacKenzie, M. R. (1984) · Hematological Oncology · doi:10.1002/hon.2900020402 · Cited by 52
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.